Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System

Recruiting

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(34 sites)

United States

Mobile Infirmary Medical Center, Mobile, Alabama

Arrhythmia Research Group-Research Facility, Jonesboro, Arkansas

University of Southern California Hospital, Los Angeles, California

Stanford University Medical Center, Stanford, California

South Denver Cardiology Associates, PC, Littleton, Colorado

HCA Florida Mercy Hospital, Miami, Florida

Naples Comprehensive Health, Naples, Florida

Emory University Hospital, Atlanta, Georgia

Memorial Health University Medical Center, Savannah, Georgia

St. Luke's Boise Medical Center, Boise, Idaho

Johns Hopkins Hospital, Baltimore, Maryland

Massachusetts General Hospital, Boston, Massachusetts

Southcoast Physicians Group, Fall River, Massachusetts

Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire

Virtua Health Inc., Marlton, New Jersey

Lovelace Medical Center, Albuquerque, New Mexico

Northwell Health, Manhasset, New York

Weill Cornell Medical University, New York, New York

Bethesda North Hospital, Cincinnati, Ohio

Ohio State University Medical Center, Columbus, Ohio

Oklahoma Heart Institute, Tulsa, Oklahoma

Trident Medical Center, Charleston, South Carolina

Texas Cardiac Arrhythmia Research, Austin, Texas

Christus Trinity Mother Frances Health System, Tyler, Texas

St. Mark's Hospital, Salt Lake City, Utah

Sentara Norfolk General Hospital, Norfolk, Virginia

Australia

John Hunter Hospital, New Lambton Heights, New South Wales

Westmead Hospital, Westmead, New South Wales

St. Andrew's War Memorial Hospital, Brisbane, Queensland

Victorian Heart Hospital, Clayton, Victoria

The Royal Melbourne Hospital, Parkville, Victoria

The Alfred Hospital, Melbourne

Taiwan

National Taiwan University Hospital, Taipei

Taipei Veterans General Hospital, Taipei